Arginine methyltransferase PRMT5 methylates and destabilizes Mxi1 to confer radioresistance in non-small cell lung cancer.

Radioresistance is regarded as the main cause of local recurrence and distant metastasis in non-small cell lung cancer. However, the underlying mechanisms of radioresistance remains incompletely understood. In this study, we find that the arginine methyltransferase PRMT5 interacts with and methylates Mxi1, which promotes the binding of the ?-Trcp ligase ...
to Mxi1, facilitating the ubiquitination and degradation of Mxi1 in lung cancer. Furthermore, genetic blockade of PRMT5 impairs DNA damage repair and enhances lung cancer radiosensitivity in vitro and in vivo, and these phenotypes are partially reversed by Mxi1 silencing. More importantly, pharmacological inhibition of PRMT5 with the specific inhibitor EPZ015666 leads to extraordinary radiosensitization in vitro and in vivo in lung cancer. Altogether, our data indicate that PRMT5 methylates and destabilizes Mxi1 to confer radioresistance, suggesting that PRMT5 may be a promising radiosensitization target in non-small cell lung cancer.
Mesh Terms:
Basic Helix-Loop-Helix Transcription Factors, Carcinoma, Non-Small-Cell Lung, Cell Line, Tumor, Humans, Intracellular Signaling Peptides and Proteins, Lung Neoplasms, Protein-Arginine N-Methyltransferases, Tumor Suppressor Proteins
Cancer Lett
Date: Dec. 28, 2021
Download Curated Data For This Publication
236364
Switch View:
  • Interactions 5